Navigation Links
Massachusetts Company May Have Silver Bullet In Vitamin D Fight Against Disease
Date:9/22/2008

WILMINGTON, Mass., Sept. 22 /PRNewswire/ -- Xenon Corp., a company internationally recognized as a leader and pioneer in the field of Pulsed Light systems, might have found the silver bullet that researchers have been seeking to increase vitamin D in their fight against disease.

It's called Pulsed light. It's brighter than the sun and in short pulses -- flashed on mushrooms -- increases the vitamin D content in mushrooms substantially.

Dole, the world's largest producer and marketer of fresh fruits and vegetables, has been treating Portobello and other mushroom varieties with light flashes and found that the vitamin D level increased significantly. In a recent article by The Packer magazine, Gary Schroeder, director of Dole Mushrooms, stated, "Research has shown that light can boost the vitamin D levels in mushrooms. Nature is trying to do this, and we're just allowing it to happen."

Professor Robert Beelman of Pennsylvania State University found that white button mushrooms, the only non-animal food that contains vitamin D, is a prime source of the antioxidant L-ERGOTHIONEINE, a powerful antioxidant that scavenges free radicals and protects the cell's DNA from damage.

"As a food scientist," Professor Beelman said, "I already knew that mushrooms were a valuable part of the diet, being a good source of B vitamins and essential minerals as well as being low in calories, fat and sodium."

"But new research is suggesting mushrooms or substances extracted from mushrooms, may have the potential to help fight cancer and heart disease. More research needs to be done in this area, but it makes powerful reading."

Professor Beelman is not alone in his findings. Many scientists and mushroom councils around the world have been researching mushrooms or substances extracted from mushrooms and are unanimous in their thoughts that mushrooms may be the new super food that could play a major role in the prevention of serious diseases such as cancer, heart disease, type 1 diabetes and a variety of other maladies.

Research seems to show that because many people are spending more time in front of computers or TV or use extra heavy sun blockers they are not getting enough sunshine, and consequently, are becoming deficient in Vitamin D. Also, people in northern climates often don't get enough sun exposure, especially in the winter, to produce adequate vitamin D.

The Xenon Pulsed light system seems to be the system of preference since it has proven highly efficient by increasing the amount of vitamin D in mushrooms in a few short bursts.

Another food application for the Xenon Pulsed light system may be in the area of killing E. coli, Salmonella and other bacteria. Recently, the Food and Drug Administration issued a regulation allowing certain food purveyors to take extra steps to prevent outbreaks of bacteria on produce.

Xenon's pulsed light may also prove a boon in this area since bursts of pulsed light could possibly clean the produce safely and efficiently.

When asked about Xenon's participation in the research, Lou Panico, CEO, remarked, "We're proud to be part of these studies. Since our start in 1964, Xenon has always strived to be on the leading edge of product development for both industrial and research applications, evidenced by our many successful achievements."

"We've strongly advocated our Pulsed light over mercury because of the countless benefits, especially since we've always considered Xenon a 'green company' with emphasis on our environment."

Xenon's system, unlike mercury, is non-toxic and completely safe for the environment. Its ultra fast processing in seconds allows low cost production and utilizes less energy than mercury's lengthy warm-up time, since it takes only a fraction of the time required by mercury systems. Xenon's Start-Stop-Start technology provides instantaneous operation.

Xenon Corporation, world leader in pulsed Light technology for a wide variety of industrial and research applications, designs and manufactures high performance pulsed lamps, curing systems and decontamination/sterilization systems.

For interviews or additional information, contact:

Lou Panico, CEO,

Xenon Corporation

37 Upton Drive Wilmington, MA 01887-1018

Tel: 978 661-9033 or 800 XENONXL

http://www.xenoncorp.com


'/>"/>
SOURCE Xenon Corporation
Copyright©2008 PR Newswire.
All rights reserved

Related biology technology :

1. IBC Life Sciences Kicks Off the 13th Annual Drug Discovery & Development of Innovative Therapeutics World Congress in Boston, Massachusetts
2. Lilly CEO Praises Massachusetts Leadership in Biotech, Urges Policy Prescriptions to Help Ensure States Investment Generates Dividends and Jobs
3. EMD Serono Announces Planned Investment of $50 Million in Research Center in Massachusetts
4. Intradigm Licenses Key Next Generation RNA Interference (RNAi) Intellectual Property From University of Massachusetts Medical School
5. Boehringer Ingelheim and BioSpace Search for Scientists at Career Fair in Boston, Massachusetts
6. BioSpace and the Massachusetts Biotechnology Council Launch 2008 Genetown(TM) Hotbed Campaign
7. Massachusetts Governor Deval L. Patrick Pays Visit to WuXi PharmaTech
8. 2007 Massachusetts Biotechnology Council MASS Opportunities Investment Conference Showcases Leading Growth Companies
9. AG Mednet Selected By Massachusetts General Hospital to Transport 3D Post-Processing Images
10. Serica Technologies Expands Facilities in Massachusetts, Combines State-Of-The-Art Textile Engineering and Biomedical Manufacturing
11. Sigma-Aldrich(R) Becomes First Life Science Company to Publish in Peer-Reviewed Video Journal JoVE
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/19/2017)... Jan. 18, 2017 The global biotechnology ... 92.9 billion by 2025, according to a new ... has been adaptive of the function of outsourcing ... 2002. Among the services outsourced, clinical trial management ... Johnson & Johnson was the first pharmaceutical company ...
(Date:1/19/2017)... BD (Becton, Dickinson and Company) (NYSE: BDX ), a ... live webcast of its Annual Meeting of Shareholders on Tuesday, January ... can be accessed from the BD corporate website at http://www.bd.com/investors/ ... ... BD is a global medical technology company that is ...
(Date:1/18/2017)... , Jan. 18, 2017   Boston Biomedical ... compounds designed to target cancer stemness pathways, will feature ... compound, napabucasin, at the 2017 ASCO Gastrointestinal Cancers Symposium, ... . Napabucasin is an orally-administered ... targeting STAT3. i Cancer stem cells (CSCs) possess ...
(Date:1/18/2017)... , ... January 18, 2017 , ... ... Clinical Ops Executives 2017 in its continued commitment to the advancement of the ... to discuss current issues related to clinical trial planning and management. , ...
Breaking Biology Technology:
(Date:12/15/2016)... , Dec. 15, 2016   WaferGen Bio-systems, ... held genomics technology company, announced today that on December ... Qualifications Department of The Nasdaq Stock Market LLC which ... bid price of WaferGen,s common stock had been at ... WaferGen has regained compliance with Listing Rule 5550(a)(2) of ...
(Date:12/15/2016)... Dec. 14, 2016 "Increase in mobile transactions ... The mobile biometrics market is expected to grow from ... by 2022, at a CAGR of 29.3% between 2016 ... as the growing demand for smart devices, government initiatives, ... "Software component is expected to grow at a ...
(Date:12/7/2016)... -- According to a new market research report "Emotion Detection and ... Recognition), Service, Application Area, End User, And Region - Global Forecast to 2021", ... Billion in 2016 to USD 36.07 Billion by 2021, at a Compound Annual ... ... MarketsandMarkets Logo ...
Breaking Biology News(10 mins):